TransVascular gains FDA go-ahead for dual lumen CrossPoint catheter:
This article was originally published in Clinica
Executive Summary
TransVascular has gained FDA 510(k) approval to sell its CrossPoint TransAccess catheter, a dual lumen device designed to facilitate the placement and positioning of catheters within the peripheral vasculature. The product is intended to avoid the guidewire becoming trapped in the vessel wall as it crosses the blockage, by aiding its return to the true lumen of the vessel. It should allow a higher percentage of peripheral angioplasty and stenting procedures to be completed successfully, said the Menlo Park, California firm.